Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

Flag Counter
  2. World Encyclopedia
  3. TrumpRx - Wikipedia
TrumpRx - Wikipedia
From Wikipedia, the free encyclopedia
TrumpRx
Type of site
Prescription drug marketplace
Available inEnglish
OwnerWhite House Office
URLtrumprx.gov
LaunchedFebruary 5, 2026

TrumpRx is a prescription drug website operated by the United States federal government. It was created in 2026.

History

Trump announcing TrumpRx in September 2025

In September 2025, Bloomberg News reported that Trump administration officials were considering establishing a website to partially fulfill U.S. president Donald Trump's demands that drugmakers reduce their prices to levels set by other countries.[1] On September 30, Trump announced TrumpRx from the Oval Office, joined by Pfizer chief executive Albert Bourla.[2] The website was set to go online in January 2026.[3]

The TrumpRx website did not launch as scheduled in January 2026. During a cabinet meeting at the White House on January 29, Health and Human Services Secretary Robert F. Kennedy Jr. mentioned that the website will be operational "in 10 days," although no specific launch date was provided.[4]

The website was launched on February 5, 2026.[5]

Service

TrumpRx is a website that offers prescription drugs at a discounted price.[2] The prices are benchmarked against those in Europe.[3] Pfizer's negotiated discounts ranged from fifty to eighty-five percent.[6]

The website does not sell drugs directly. Rather, it enables consumers to buy specific prescription medications directly from pharmaceutical companies at reduced prices, without going through their insurance. The aim is to reduce out-of-pocket expenses for consumers, especially those who pay cash or do not have extensive drug coverage.[7]

The website is designed by the National Design Studio.[8]

Drugs

According to an initial statement from the Trump administration, TrumpRx will provide Eucrisa, Xeljanz, and Zavzpret.[2] In October 2025, the Trump administration reached a deal with AstraZeneca;[9] a website from AstraZeneca, named AstraZeneca Direct,[10] included Farxiga, Airsupra, and FluMist as eligible for direct pricing.[9] That month, EMD Serono agreed to offer its gonadotropin preparation drugs, including Gonal-f,[11] on TrumpRx.[12] AmgenNow, a website from Amgen that offers Repatha, is additionally set to appear on TrumpRx.[13]

At its launch on February 5, 2026, 43 drugs are available on TrumpRx.[14] The White House plans to add more drugs over time.[15] As of February 2026, over half of the medications on TrumpRx currently have or will soon have a more affordable generic version available through various direct-to-consumer platforms, including GoodRx and Mark Cuban's Cost Plus Drugs.[16] A White House spokesperson mentioned that while cheaper alternatives may exist for certain items on TrumpRx, the site's main advantage lies in offering the lowest-cost options for branded products.[17]

Responses

Political

Bloomberg News described TrumpRx as an instance of Trump using the federal government as an avenue for shareholder activism.[18]

Senate Democrats, including Ron Wyden, have characterized TrumpRx as resembling a marketing or coupon-based strategy that fails to effectively lower pharmacy costs for the majority of Americans.[19] They have called for the disclosure of the terms negotiated with manufacturers such as Pfizer and AstraZeneca and have urged regulators to delay the implementation of the initiative until these questions are addressed.[20] Democratic lawmakers also highlight their own policy proposals such as Medicare negotiation, oversight of pharmaceutical benefit managers (PBMs), and price caps on essential medications as more effective means of reducing drug prices, asserting that TrumpRx does not enhance or replace these measures.[21][22][23]

Democratic Senators Dick Durbin, Elizabeth Warren, and Peter Welch raised concerns regarding questionable prescribing practices, potential conflicts of interest, and insufficient care related to the specific types of direct-to-consumer (DTC) platforms to which TrumpRx would direct patients.[24] California Governor Gavin Newsom described TrumpRx as a copy of CalRx, which set the insulin price at a maximum of $11.[25]

Industry and health

The deal reached with the Trump administration secured Pfizer a reprieve from tariffs on the pharmaceutical industry, threatened to be 100 percent.[26]

According to The New York Times, TrumpRx does not provide meaningful discounts for insurance beneficiaries.[27]

Public opinion

A February 2026 YouGov survey found broad support for the new government website when it is not called TrumpRx: 57% approve and 19% disapprove. When the name TrumpRx is used, approval drops to 41% and disapproval rises to 31%. The name has the strongest negative effect among Democrats. Approval falls from 45% to 13% when TrumpRx is mentioned, and disapproval jumps from 27% to 62%. Independents show a similar pattern: approval drops from 49% to 21%, and opinions split evenly (31% approve, 31% disapprove) when the name is used. Republican support remains steady, with strong approval whether or not the name is cited (78% vs. 81%). Mentioning TrumpRx also reduces intended use overall: those “not at all likely” to use the site rise from 35% to 44%. Democrats’ reluctance increases sharply (50% to 74%), as does Independents’ (32% to 45%). Republicans, however, become more likely to use it when the name is mentioned, with “not at all likely” dropping from 23% to 15% and “very likely” rising from 9% to 20%. Overall, the name boosts Republican enthusiasm but lowers broader public support and usage.[28]

See also

References

  1. ^ Zhang & Woodhouse 2025.
  2. ^ a b c Andrews, Whyte & Loftus 2025.
  3. ^ a b Robbins & Sanger-Katz 2025a.
  4. ^ Manalac, Tristan (30 January 2026). "TrumpRx Delayed Amid Potential Anti-Kickback Concerns". BioSpace. Retrieved 2 February 2026.
  5. ^ Salas, Christopher (February 5, 2026). "President Trump launches TrumpRx: Who will save on drug costs?". KCRA 3 News. Hearst Television. Retrieved February 5, 2026.
  6. ^ Temple-West 2025.
  7. ^ "What is Trump's new Trumprx website and will it bring medicine prices down?". Al Jazeera. October 3, 2025. Retrieved November 17, 2025.
  8. ^ Chen, Elaine; Wilkerson, John; Cirruzzo, Chelsea (February 5, 2026). "What to know about TrumpRx, the Trump administration's prescription drug platform". STAT. STAT News. Retrieved February 6, 2026.
  9. ^ a b Robbins & Sanger-Katz 2025b.
  10. ^ Zhang, Muller & Furlong 2025.
  11. ^ Zhang, Nix & Wind 2025.
  12. ^ Kitchener et al. 2025.
  13. ^ Muller 2025.
  14. ^ Cerullo, Megan (6 February 2026). "TrumpRx: See the 43 drugs available on the Trump administration's new discounted drug site". CBS News. Retrieved 7 February 2026.
  15. ^ "President Trump Launches TrumpRx.gov, Delivering Massive, Immediate Savings to Millions of Americans". The White House. whitehouse.gov. February 6, 2026. Retrieved February 7, 2026.
  16. ^ Wilkerson, John; Parker, J. Emory; Cirruzzo, Chelsea; Chen, Elaine; Payne, Daniel (February 6, 2026). "TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics". STAT. Stat News. Retrieved February 10, 2026.
  17. ^ Goldman, Maya (6 February 2026). "More than half of TrumpRx drugs have a cheaper alternative". Axios. Retrieved 10 February 2026.
  18. ^ Levine & Wagner 2025.
  19. ^ Wilson, Megan R. (6 February 2026). "TrumpRx's price problem". The Washington Post. Retrieved 10 February 2026.
  20. ^ Quinton, Gavin J. (7 February 2026). "TrumpRx is launched: How it works and what Democrats say about it". Los Angeles Times. Retrieved 10 February 2026.
  21. ^ "Wyden Statement on TrumpRX Announcement". U.S. Senate Committee on Finance. 2026-02-06. Retrieved 2026-02-10.
  22. ^ "Wyden, Senate Democrats Blast Trump's Drug Pricing Fraud, Lay Out Agenda for Lower Prices". U.S. Senate Committee on Finance. 2026-02-04. Retrieved 2026-02-10.
  23. ^ Johnson, Jake (6 February 2026). "TrumpRx Denounced as Corrupt Scheme to Line Pockets of Big Pharma—and Don Jr". Common Dreams. Retrieved 10 February 2026.
  24. ^ Mole, Beth (31 January 2026). "TrumpRx delayed as senators question if it's a giant scam with Big Pharma". Ars Technica. Retrieved 2 February 2026.
  25. ^ "Trump is taking Governor Newsom's work nationwide. Learn about President Trump's copycat efforts". Governor of California. State of California. January 14, 2026. Retrieved January 17, 2026.
  26. ^ Garde, Zhang & Lowenkron 2025.
  27. ^ Robbins 2025.
  28. ^ Rossell Hayes, Alexander (February 17, 2026). "Many Americans like the concept of TrumpRx, but the name turns off some of them". YouGov. YouGov. Retrieved February 20, 2026.

Works cited

Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id